Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Urol Int
    June 2017
  1. NAGAO K, Hara T, Nishijima J, Shimizu K, et al
    The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Urol Int. 2017 Jun 21. doi: 10.1159/000477912.
    >> Share

  2. POLETAJEW S, Zapala P, Radziszewski P
    Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
    Urol Int. 2017 Jun 10. doi: 10.1159/000477673.
    >> Share

    April 2017
  3. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    >> Share

    March 2017
  4. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    >> Share

    February 2017
  5. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    >> Share

    January 2017
  6. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    >> Share

  7. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    >> Share

    December 2016
  8. BREYER J, Otto W, Wirtz RM, Wullich B, et al
    ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Urol Int. 2016.
    >> Share

  9. D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
    90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
    Urol Int. 2016.
    >> Share

    September 2016
  10. BURGE F, Kockelbergh R
    Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes.
    Urol Int. 2016.
    >> Share

    July 2016
  11. SIKIC D, Wach S, Taubert H, Richterstetter M, et al
    How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience.
    Urol Int. 2016.
    >> Share

    February 2016
  12. ZAKARIA AS, Santos F, Kassouf W, Tanguay S, et al
    Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec.
    Urol Int. 2016.
    >> Share

  13. FAHMY O, Scharpf M, Schubert T, Feyerabend S, et al
    Ten Years of Complete Remission of Pulmonary Metastasis after Post-Cystectomy Palliative Cisplatin-Gemcitabine Chemotherapy with Gefitinib for Muscle Invasive Bladder Cancer: A Case Report.
    Urol Int. 2016.
    >> Share

    January 2016
  14. NOVOTNY V, Froehner M, Ollig J, Koch R, et al
    Impact of Adjuvant Intravesical Bacillus Calmette-Guerin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Urol Int. 2016.
    >> Share

  15. VILASECA A, Huguet J, Perez M, Camacho D, et al
    The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer.
    Urol Int. 2016.
    >> Share

  16. GAKIS G, Rink M, Fritsche HM, Graefen M, et al
    Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2016.
    >> Share

  17. CHEN Y, Yang Y, Liu L, Wang S, et al
    Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2016;96:142-7.
    >> Share

  18. SOORIAKUMARAN P, Chiocchia V, Dutton S, Pai A, et al
    Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
    Urol Int. 2016;96:83-90.
    >> Share

  19. SERRETTA V, Scalici Gesolfo C, Alonge V, Cicero G, et al
    Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
    Urol Int. 2016;96:20-4.
    >> Share

  20. MARTINI T, Aziz A, Roghmann F, Rink M, et al
    Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
    Urol Int. 2016;96:57-64.
    >> Share

  21. MILLER K, Morant R, Stenzl A, Zuna I, et al
    A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transi
    Urol Int. 2016;96:5-13.
    >> Share

  22. TANAKA H, Yoshida S, Komai Y, Sakai Y, et al
    Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Urol Int. 2016;96:65-72.
    >> Share

  23. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    >> Share

  24. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    >> Share

    November 2015
  25. HOFBAUER SL, Shariat SF, Chade DC, Sarkis AS, et al
    The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
    Urol Int. 2015.
    >> Share

    October 2015
  26. HORN T, Zahel T, Adt N, Schmid SC, et al
    Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
    Urol Int. 2015.
    >> Share

    September 2015
  27. BRISUDA A, Pazourkova E, Soukup V, Horinek A, et al
    Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Urol Int. 2015.
    >> Share

    August 2015
  28. LATZ S, Umbach T, Goltz D, Kristiansen G, et al
    Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
    Urol Int. 2015.
    >> Share

    May 2015
  29. HUPE MC, Merseburger AS, Gunter HH, Wustemann M, et al
    Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature.
    Urol Int. 2015.
    >> Share

    January 2015
  30. AZIZ A, Madersbacher S, Otto W, Mayr R, et al
    Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
    Urol Int. 2015;94:37-44.
    >> Share

  31. COMPLOJ E, West J, Mian M, Kluth LA, et al
    Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
    Urol Int. 2015;94:25-30.
    >> Share

  32. LIU B, Zhang C, Zhang Q, Liu G, et al
    Primary epithelioid hemangioendothelioma of the bladder: case report and review of the literature.
    Urol Int. 2015;94:240-3.
    >> Share

  33. LEI Y, Tong S, Zu X, Li Y, et al
    Extraperitoneal and transperitoneal laparoscopic partial cystectomy for benign non-urothelial bladder tumors: an initial experience.
    Urol Int. 2015;94:149-55.
    >> Share

  34. WANG Y, Wang T, Han Y, Wu H, et al
    Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.
    Urol Int. 2015;94:464-71.
    >> Share

  35. GARDE H, Ciappara M, Galante I, Fuentes Ferrer M, et al
    Radical cystectomy in octogenarian patients: a difficult decision to take.
    Urol Int. 2015;94:390-3.
    >> Share

  36. ESWARA JR, Heney NM, Wu CL, McDougal WS, et al
    Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
    Urol Int. 2015;94:401-5.
    >> Share

  37. BERGER I, Wehrberger C, Ponholzer A, Wolfgang M, et al
    Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older.
    Urol Int. 2015;94:394-400.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016